Prophylactic use of NSAIDs by athletes: A risk/benefit assessment

Physician and Sportsmedicine

Volumn 38, Issue 1, 2010, Pages 132-138

  Warden, Stuart J ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Athletes; Nonsteroidal anti inflammatory drugs; Prophylactic; Side effects; Sports medicine

Indexed keywords

NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT;

ANALGESIC ACTIVITY; ATHLETE; ATHLETIC PERFORMANCE; CARDIOVASCULAR DISEASE; DRUG MISUSE; DRUG SELF ADMINISTRATION; DRUG USE; GASTROINTESTINAL SYMPTOM; HUMAN; INFLAMMATION; KIDNEY DISEASE; MUSCULOSKELETAL DISEASE; NONHUMAN; PAIN; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SPORTS MEDICINE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATHLETIC INJURIES; GASTROINTESTINAL HEMORRHAGE; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION; PAIN; PHYSICAL ENDURANCE; RISK ASSESSMENT;

EID: 77950849829     PISSN: 00913847     EISSN: None     Source Type: Journal    
DOI: 10.3810/psm.2010.04.1770     Document Type: Review

References (76)

1. Corrigan B, Kazlauskas R. Medication use in athletes selected for doping control at the Sydney Olympics (2000). Clin J Sport Med. 2003;13(1): 33-40. (Pubitemid 36142924)
2. Huang SH, Johnson K, Pipe AL. The use of dietary supplements and medications by Canadian athletes at the Atlanta and Sydney Olympic Games. Clin J Sport Med. 2006;16(1):27-33. (Pubitemid 43068392)
3. Suzic Lazic J, Dikic N, Radivojevic N, et al. Dietary supplements and medications in elite sport - polypharmacy or real need? [published online ahead of print November 5, 2009]. Scand J Med Sci Sports.
4. Thuyne WV, Delbeke FT. Declared use of medication in sports. Clin J Sport Med. 2008;18(2):143-147.
5. Tsitsimpikou C, Jamurtas A, Fitch K, Papalexis P, Tsarouhas K. Medication use by athletes during the Athens 2004 Paralympic Games. Br J Sports Med. 2009;43(13):1062-1066.
6. Tsitsimpikou C, Tsiokanos A, Tsarouhas K, et al. Medication use by athletes at the Athens 2004 Summer Olympic Games. Clin J Sport Med. 2009;19(1):33-38.
7. Berglund B. Sports medicine update. Scand J Med Sci Sports. 2001;11(6):369-371.
8. Alaranta A, Alaranta H, Heliövaara M, Airaksinen M, Helenius I. Ample use of physician-prescribed medications in Finnish elite athletes. Int J Sports Med. 2006;27(11):919-925. (Pubitemid 44759327)
9. Tscholl P, Feddermann N, Junge A, Dvorak J. The use and abuse of pain-killers in international soccer: data from 6 FIFA tournaments for female and youth players. Am J Sports Med. 2009;37(2):260-265.
10. Tscholl P, Junge A, Dvorak J. The use of medication and nutritional supplements during FIFA World Cups 2002 and 2006. Br J Sports Med. 2008;42(9):725-730.
11. Warden SJ. Prophylactic misuse and recommended use of non-steroidal anti-inflammatory drugs by athletes. Br J Sports Med. 2009;43(8): 548-549.
12. Warner DC, Schnepf G, Barrett MS, Dian D, Swigonski NL. Prevalence, attitudes, and behaviors related to the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in student athletes. J Adolesc Health. 2002;30(3): 150-153. (Pubitemid 34175138)
13. Gambero A, Becker TL, Zago AS, de Oliveira AF, Pedrazzoli J Jr. Comparative study of anti-inflammatory and ulcerogenic activities of different cyclo-oxygenase inhibitors. Inflammopharmacology. 2005;13(5-6): 441-454. (Pubitemid 41775523)
14. Pinheiro RM, Calixto JB. Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation. Inflamm Res. 2002;51(12):603-610.
15. Buvanendran A, Kroin JS, Tuman KJ, et al. Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomized controlled trial. JAMA. 2003;290(18):2411-2418. (Pubitemid 37430540)
16. Huang YM, Wang CM, Wang CT, Lin WP, Horng LC, Jiang CC. Perioperative celecoxib administration for pain management after total knee arthroplasty - a randomized, controlled study. BMC Musculoskelet Disord. 2008;9:77.
17. O'Grady M, Hackney AC, Schneider K, et al. Diclofenac sodium (Voltaren) reduced exercise-induced injury in human skeletal muscle. Med Sci Sports Exerc. 2000;32(7):1191-1196. (Pubitemid 30482644)
18. Pizza FX, Cavender D, Stockard A, Baylies H, Beighle A. Anti-inflammatory doses of ibuprofen: effect on neutrophils and exercise-induced muscle injury. Int J Sports Med. 1999;20(2):98-102. (Pubitemid 29112667)
19. Sayers SP, Knight CA, Clarkson PM, Van Wegen EH, Kamen G. Effect of ketoprofen on muscle function and sEMG activity after eccentric exercise. Med Sci Sports Exerc. 2001;33(5):702-710. (Pubitemid 32336628)
20. Lapointe BM, Frémont P, Côté CH. Influence of nonsteroidal anti-inflammatory drug treatment duration and time of onset on recovery from exercise-induced muscle damage in rats. Arch Phys Med Rehabil. 2003;84(5):651-655.
21. Donnelly AE, Maughan RJ, Whiting PH. Effects of ibuprofen on exercise-induced muscle soreness and indices of muscle damage. Br J Sports Med. 1990;24(3):191-195.
22. Gulick DT, Kimura IF, Sitler M, Paolone A, Kelly JD. Various treatment techniques on signs and symptoms of delayed onset muscle soreness. J Athl Train. 1996;31(2):145-152.
23. Mikkelsen UR, Langberg H, Helmark IC, et al. Local NSAID infusion inhibits satellite cell proliferation in human skeletal muscle after eccentric exercise. J Appl Physiol. 2009;107(5):1600-1611.
24. Nieman DC, Dumke CL, Henson DA, McAnulty SR, Gross SJ, Lind RH. Muscle damage is linked to cytokine changes following a 160-km race. Brain Behav Immun. 2005;19(5):398-403. (Pubitemid 41074778)
25. Nieman DC, Henson DA, Dumke CL, et al. Ibuprofen use, endotoxemia, inflammation, and plasma cytokines during ultramarathon competition. Brain Behav Immun. 2006;20(6):578-584.
26. Paulsen G, Egner IM, Drange M, et al. A COX-2 inhibitor reduces muscle soreness, but does not influence recovery and adaptation after eccentric exercise [published online ahead of print June 10, 2009]. Scand J Med Sci Sports.
27. Peterson JM, Trappe TA, Mylona E, et al. Ibuprofen and acetaminophen: effect on muscle inflammation after eccentric exercise. Med Sci Sports Exerc. 2003;35(6):892-896. (Pubitemid 36706274)
28. Tokmakidis SP, Kokkinidis EA, Smilios I, Douda H. The effects of ibuprofen on delayed muscle soreness and muscular performance after eccentric exercise. J Strength Cond Res. 2003;17(1):53-59. (Pubitemid 36313312)
29. Khan KM, Bonar F, Desmond PM, et al. Patellar tendinosis (jumper's knee): findings at histopathologic examination, US, and MR imaging. Victorian Institute of Sport Tendon Study Group. Radiology. 1996;200(3):821-827.
30. Lemont H, AmmiratiKM, Usen N. Plantar fasciitis: a degenerative process (fasciosis) without inflammation. J Am Podiatr Med Assoc. 2003;93(3):234-237. (Pubitemid 38469508)
31. Potter HG, Hannafin JA, Morwessel RM, DiCarlo EF, O'Brien SJ, Altchek DW. Lateral epicondylitis: correlation of MR imaging, surgical, and histopathologic findings. Radiology. 1995;196(1):43-46.
32. Alexopoulou A, Dourakis SP, Mantzoukis D, et al. Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece. Eur J Intern Med. 2008;19(7):505-510.
33. Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc. 2002;50(12):1962-1968. (Pubitemid 35462441)
34. González EL, Patrignani P, Tacconelli S, Rodríguez LA. Variability of risk of upper gastrointestinal bleeding among nonsteroidal anti-inflammatory drugs [published online ahead of print February 22, 2010]. Arthritis Rheum.
35. Lanas A, Garcia-Rodríguez LA, Arroyo MT, et al; Asociación Española de Gastroenterología. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut. 2006;55(12):1731-1738.
36. Jones R, Rubin G, Berenbaum F, Scheiman J. Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs. Am J Med. 2008;121(6):464-474. (Pubitemid 351694347)
37. Lanas A. Nonsteroidal antiinflammatory drugs and cyclooxygenase inhibition in the gastrointestinal tract: a trip from peptic ulcer to colon cancer. Am J Med Sci. 2009;338(2):96-106.
38. Lambert GP, Boylan M, Laventure JP, Bull A, Lanspa S. Effect of aspirin and ibuprofen on GI permeability during exercise. Int J Sports Med. 2007;28(9):722-726. (Pubitemid 47414160)
39. Smetanka RD, Lambert GP, Murray R, Eddy D, Horn M, GisolfiCV. Intestinal permeability in runners in the 1996 Chicago marathon. Int J Sport Nutr. 1999;9(4):426-433.
40. Farkouh ME, Greenberg BP. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs. Am J Cardiol. 2009;103(9):1227-1237.
41. Fosbøl EL, Gislason GH, Jacobsen S, et al. Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study. Clin Pharmacol Ther. 2009;85(2):190-197.
42. Warden SJ. Cyclo-oxygenase-2 inhibitors: beneficial or detrimental for athletes with acute musculoskeletal injuries? Sports Med. 2005;35(4): 271-283.
43. Warden SJ, Fuchs RK. Exercise and bone health: optimising bone structure during growth is key, but all is not in vain during ageing. Br J Sports Med. 2009;43(12):885-887.
44. Chow JW, Chambers TJ. Indomethacin has distinct early and late actions on bone formation induced by mechanical stimulation. Am J Physiol. 1994;267(2 pt 1):E287-E292. (Pubitemid 24272445)
45. Forwood MR. Inducible cyclo-oxygenase (COX-2) mediates the induction of bone formation by mechanical loading in vivo. J Bone Miner Res. 1996;11(11):1688-1693.
46. Li J, Burr DB, Turner CH. Suppression of prostaglandin synthesis with NS-398 has different effects on endocortical and periosteal bone formation induced by mechanical loading. Calcif Tissue Int. 2002;70(4): 320-329. (Pubitemid 36935448)
47. Kohrt WM, Barry DW, Van Pelt RE, Jankowski CM, Wolfe P, Schwartz RS. Timing of ibuprofen use and bone mineral density adaptations to exercise training [published online ahead of print January 14, 2010]. J Bone Miner Res.
48. Warden SJ, Hurst JA, Sanders MS, Turner CH, Burr DB, Li J. Bone adaptation to a mechanical loading program significantly increases skeletal fatigue resistance. J Bone Miner Res. 2005;20(5):809-816. (Pubitemid 40571638)
49. Novak ML, Billich W, Smith SM, et al. COX-2 inhibitor reduces skeletal muscle hypertrophy in mice. Am J Physiol Regul Integr Comp Physiol. 2009;296(4):R1132-R1139.
50. Soltow QA, Betters JL, Sellman JE, Lira VA, Long JH, Criswell DS. Ibuprofen inhibits skeletal muscle hypertrophy in rats. Med Sci Sports Exerc. 2006;38(5):840-846.
51. Ekman EF, Fiechtner JJ, Levy S, Fort JG. Efficacy of celecoxib versus ibuprofen in the treatment of acute pain: a multicenter, double-blind, randomized controlled trial in acute ankle sprain. Am J Orthop. 2002;31(8):445-451.
52. Ekman EF, RuoffG, Kuehl K, et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. Am J Sports Med. 2006;34(6):945-955.
53. Allen HL, Wase A, Bear WT. Indomethacin and aspirin: effect of nonsteroidal anti-inflammatory agents on the rate of fracture repair in the rat. Acta Orthop Scand. 1980;51(4):595-600. (Pubitemid 10090468)
54. Lindholm TS, Tornkvist H. Inhibitory effect on bone formation and calcification exerted by the anti-inflammatory drug ibuprofen. An experimental study on adult rat with fracture. Scand J Rheumatol. 1981;10(1):38-42. (Pubitemid 11114040)
55. Simon AM, Manigrasso MB, O'Connor JP. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res. 2002;17(6): 963-976. (Pubitemid 34535133)
56. Cohen DB, Kawamura S, Ehteshami JR, Rodeo SA. Indomethacin and celecoxib impair rotator cufftendon-to-bone healing. Am J Sports Med. 2006;34(3):362-369. (Pubitemid 43260571)
57. Dimmen S, Engebretsen L, Nordsletten L, Madsen JE. Negative effects of parecoxib and indomethacin on tendon healing: an experimental study in rats. Knee Surg Sports Traumatol Arthrosc. 2009;17(7):835-839.
58. Dimmen S, Nordsletten L, Madsen JE. Parecoxib and indomethacin delay early fracture healing: a study in rats. Clin Orthop Relat Res. 2009;467(8):1992-1999.
59. Elder CL, Dahners LE, Weinhold PS. A cyclooxygenase-2 inhibitor impairs ligament healing in the rat. Am J Sports Med. 2001;29(6):801-805.
60. Ferry ST, Dahners LE, Afshari HM, Weinhold PS. The effects of common anti-inflammatory drugs on the healing rat patellar tendon. Am J Sports Med. 2007;35(8):1326-1333.
61. Shen W, Li Y, Tang Y, Cummins J, Huard J. NS-398, a cyclooxygenase-2- specific inhibitor, delays skeletal muscle healing by decreasing regeneration and promoting fibrosis. Am J Pathol. 2005;167(4):1105-1117. (Pubitemid 41416261)
62. Warden SJ, Avin KG, Beck EM, DeWolf ME, Hagemeier MA, Martin KM. Low-intensity pulsed ultrasound accelerates and a nonsteroidal anti-inflammatory drug delays knee ligament healing. Am J Sports Med. 2006;34(7):1094-1102.
63. Abdul-Hadi O, Parvizi J, Austin MS, Viscusi E, Einhorn T. Nonsteroidal antiinflammatory drugs in orthopaedics. J Bone Joint Surg Am. 2009;91(8):2020-2027.
64. Gerstenfeld LC, Al-Ghawas M, Alkhiary YM, et al. Selective and nonselective cyclooxygenase-2 inhibitors and experimental fracture-healing. Reversibility of effects after short-term treatment. J Bone Joint Surg Am. 2007;89(1):114-125. (Pubitemid 46059150)
65. Simon AM, O'Connor JP. Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing. J Bone Joint Surg Am. 2007;89(3):500-511. (Pubitemid 46365350)
66. Trappe TA, Fluckey JD, White F, Lambert CP, Evans WJ. Skeletal muscle PGF(2)(alpha) and PGE(2) in response to eccentric resistance exercise: influence of ibuprofen acetaminophen. J Clin Endocrinol Metab. 2001;86(10):5067-5070. (Pubitemid 33020565)
67. Mackey AL, Kjaer M, Dandanell S, et al. The influence of antiinflammatory medication on exercise-induced myogenic precursor cell responses in humans. J Appl Physiol. 2007;103(2):425-431. (Pubitemid 47204959)
68. Trappe TA, White F, Lambert CP, Cesar D, Hellerstein M, Evans WJ. Effect of ibuprofen and acetaminophen on postexercise muscle protein synthesis. Am J Physiol Endocrinol Metab. 2002;282(3):E551-E556. (Pubitemid 34654769)
69. Hao CM, Breyer MD. Physiological regulation of prostaglandins in the kidney. Annu Rev Physiol. 2008;70:357-377.
70. Poortmans JR. Exercise and renal function. Sports Med. 1984;1(2): 125-153.
71. Baker J, Cotter JD, Gerrard DF, Bell ML, Walker RJ. Effects of indomethacin and celecoxib on renal function in athletes. Med Sci Sports Exerc. 2005;37(5):712-717. (Pubitemid 40628273)
72. Farquhar WB, Morgan AL, Zambraski EJ, Kenney WL. Effects of acetaminophen and ibuprofen on renal function in the stressed kidney. J Appl Physiol. 1999;86(2):598-604.
73. Walker RJ, Fawcett JP, Flannery EM, Gerrard DF. Indomethacin potentiates exercise-induced reduction in renal hemodynamics in athletes. Med Sci Sports Exerc. 1994;26(11):1302-1306.
74. Davis DP, Videen JS, Marino A, et al. Exercise-associated hyponatremia in marathon runners: a two-year experience. J Emerg Med. 2001;21(1): 47-57. (Pubitemid 32496498)
75. Page AJ, Reid SA, Speedy DB, Mulligan GP, Thompson J. Exercise-associated hyponatremia, renal function, and nonsteroidal antiinflammatory drug use in an ultraendurance mountain run. Clin J Sport Med. 2007;17(1):43-48. (Pubitemid 46279923)
76. Wharam PC, Speedy DB, Noakes TD, Thompson JM, Reid SA, Holtzhausen LM. NSAID use increases the risk of developing hyponatremia during an Ironman triathlon. Med Sci Sports Exerc. 2006;38(4): 618-622.